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Background. Spontaneous recanalization of a chronically occluded artery is rare and reported anecdotally. Case Summary. We
report a case of a patient with a chronically occluded right coronary artery, found on a coronary angiography performed due to
acute ST elevation myocardial infarction with an occluded circumﬂex artery as a culprit lesion. Three months later, a follow-up
angiography was performed and a recanalization of the occluded right coronary artery was detected. Discussion. There is a
possibility that intrinsic ﬁbrinolytic mechanisms with the additional eﬀect of standard antithrombotic drugs administrated after
the acute coronary event led to the recanalization.
1. Introduction
Chronic total occlusion (CTO) of a coronary artery is deﬁned
as an occlusion > 6 weeks with well-developed collaterals
which may provide ﬂow equivalent to a ﬂow obtained in an
artery with 90-95% stenosis, preventing myocardial ischemia
[1–4]. Although a spontaneous recanalization can occur in
the acute myocardial infarction caused by a thrombotic
event, it is a rare event in CTOs, especially in native coronary
arteries occluded by a solid ﬁbrocalciﬁc plaque. We report a
case of a female patient with a spontaneously recanalized
CTO of the right coronary artery (RCA).
2. Case Report
A 67-year-old woman with a history of asthma presented to
the Emergency Department (ED) with chest pain lasting 3
hours before admission. The 12-lead ECG revealed myocar-
dial infarction with ST segment elevation (STEMI) (elevation
present in the inferior and V5/V6 leads) (Figures 1(a)–1(c)).
The patient was hemodynamically stable with normal blood
pressure and Killip status I. After applying a bolus dose of
acetylsalicylic acid (300 mg) and ticagrelor (180 mg) orally,
an urgent coronary angiography was performed which
showed a middle segment left circumﬂex artery (LCx)
occlusion and a collateralized total occlusion of the proxi-
mal segment of RCA. Three drug-eluting stents (DES)
were implanted in the LCx, and due to unsatisfactory
postprocedural TIMI ﬂow (TIMI I), GP IIb/IIIa inhibitor
eptiﬁbatide was applied after the procedure (180 mcg/kg
as a IV bolus—15,3 mg, followed by a continuous infusion
of 2 mcg/kg/min up to 75 mg of eptiﬁbatide in total)
(Figures 2–4). Postprocedural ECG revealed satisfactory ST
segment resolution, and the patient had no chest pain. Labo-
ratory tests revealed elevation of cardioselective markers
(admission values: hsTI 51 ng/L and creatine kinase 106
U/L; peak values during hospitalization, 18 hours after the
intervention: hsTI 24100 ng/L and creatine kinase 1348
U/L). Echocardiography during the ﬁrst day after procedure
showed a preserved left ventricular ejection fraction (50%)
with a inferoposterior wall hypokinesis, with no other signif-
icant pathology. The patient was treated with beta blocker,
ACE inhibitor, and statin permanently as well as with a 100
IU/kg dose of low-molecule heparin (enoxaparin) twice a
day during the ﬁrst 4 days. On the 5th day of the hospitali-
zation, the patient reported nonspeciﬁc chest discomfort,
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Figure 1: Continued.
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Figure 1: Continued.
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without cardioselective enzyme reelevation, but due to non-
speciﬁc changes in the inferior leads of the ECG, the new
onset of the ischemia could not be excluded, so the coronary
angiography was repeated. The second coronary angiogra-
phy revealed CTO of the RCA and an in-stent thrombosis
with occlusion of stents in LCx (Figure 5). Due to unsuccess-
ful recanalization of the LCx using the guidewire and the
TIMI I ﬂow at the end of the ﬁrst procedure, optimal anti-
ischemic therapy was proposed including isosorbide-mono-
nitrate, trimetazidine, ranolazine, in addition to ticagrelor,
(c)
Figure 1: (a) ECG at admission (I, II, III, aVF, aVL, and aVF). (b) ECG at admission (V1-V6). (c) ECG at admission (right leads).
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acetylsalicylic acid (ASA), nebivolol, ramipril, and atorva-
statin. After the following four days of uneventful hospitali-
zation, the patient was discharged with chronic therapy
which included all the abovementioned medications. Three
months later, at the planned outpatient follow-up visit, the
patient presented with stable angina pectoris symptoms dur-
ing moderate physical activity and a new coronary angiogra-
phy was scheduled. After admission, coronary angiography
was performed showing a spontaneous recanalization of the
RCA, with a nonsigniﬁcant stenosis of the proximal-to-
middle RCA segment, a 50% stenosis of the posterior
descending artery, and no collaterals from left anterior
descending artery (LAD) as well as persistent in-stent occlu-
sion in the LCx with new collaterals from the ﬁrst marginal
artery (Figure 6). Dobutamine stress echocardiography was
performed the day after the coronary angiography, showing
no ischemia progression during testing in the RCA- and
LCx-supplied myocardium. Due to stress echocardiography
ﬁnding, no coronary intervention was indicated. Medical
therapy was continued after dose optimization (80 mg of
isosorbide-mononitrate daily instead of 40 mg and 1000 mg
of ranolazine daily instead of 750 mg). Before discharge, an
optimal ECG stress test was performed and no pain or ECG
signs of ischemia were reported.
3. Discussion
We report a noninvasive CTO recanalization of the RCA.
According to available data, a spontaneous recanalization
of chronically occluded coronary arteries has been described
anecdotally [5, 6]. All the cases (including ours) described
CTO recanalization of the right coronary artery in the 60-
year-old women. The majority of cases described CTO
recanalization of carotid and peripheral arteries followed
by discussion about the underlying mechanism [7–9]. In
comparison to the reported cases with spontaneous CTO
coronary artery recanalization, there are several speciﬁcities
of our case. Firstly, no signiﬁcant residual stenosis at the site
of the previous CTO was noted, except a nonsigniﬁcant
proximal-to-middle segment stenosis of the RCA [5, 6].
Secondly, the stimulation of the intrinsic ﬁbrinolytic path-
way by the anoxic tissue has been proposed as an under-
ling mechanism of the discussed phenomenon [9]. In the
reported case, acute therapy with low-molecule heparin and
the GP IIb/IIIa inhibitor eptiﬁbatide did not aﬀect the
Figure 5: In-stent thrombosis of the left circumﬂex artery (LCx).
Figure 2: Occlusion of the middle segment of the left circumﬂex
artery (LCx) (image after a partial recanalization with a guidewire).
Figure 3: Left anterior descending artery (LAD) with collaterals to
the right coronary artery (RCA).
Figure 4: Chronic total occlusion (CTO) of the proximal right
coronary artery (RCA) segment.
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chronic occlusion which was conﬁrmed by a control angiog-
raphy performed 5 days after the acute infarction. However,
the addition of dual antiplatelet therapy in a chronic setting
may be added a synergistic eﬀect to intrinsic mechanisms
and led to the recanalization in less than three months. It
raises the question why the CTO was recanalized and the
stents remained occluded. The fact that stents are “foreign”
objects in the coronary arteries with a chance of acute and
chronic thrombosis supports the hypothesis that thrombosis
activated intrinsic ﬁbrinolytic pathways, but stents in the LCx
encouraged the thrombosis or made it diﬃcult to intrinsic
ﬁbrinolysis to make the artery patent again. Thirdly, there
is a suspicion that the RCA was a culprit lesion of the acute
infarction. However, there are few arguments against the
RCA occlusion as a culprit infarction lesion: the initial ECG
showed a inferolateral ST segment elevation with a slightly
higher elevation in the 2nd standard lead (II) than in the
3rd lead, without a signiﬁcant “mirror” ST segment denivela-
tion in the 1st standard lead and without elevation in the
right precordial leads (RV4) (Figures 1(a)–1(c)); no ischemic
pain and satisfactory ST segment resolution were present
after the acute intervention on the LCx occlusion; there were
already existing collaterals from LAD to RCA; and no medi-
cally induced reperfusion of the RCA occlusion was obtained
(conﬁrmed by a control angiography 5 days after the index
event) after applying ticagrelor, acetylsalicylic acid, eptiﬁba-
tide, and low-molecule heparin in the acute setting. It is pos-
sible that excessive antithrombotic and anticoagulant therapy
gave a “bite” to the chronic occlusion of the RCA, leading to
the intrinsic ﬁbrinolytic mechanism and medical thrombotic
suppression to melt the chronic occlusion. On the other
hand, stopping the heparin and GPII/IIIa therapy in a still
acute prothrombotic milieu led to thrombosis of the three
implanted stents in the LCx. Additionally, it remains unclear
why the patient reported angina between two hospitaliza-
tions, especially after performing a stress echocardiography
where no ischemia progression was found. There might
be an angiographic undetectable underlying microvascular
disease which symptoms’ regression can be related to the
therapy changes (control ECG stress test revealed no ECG
signs of ischemia nor clinical AP symptoms). Although
intravascular ultrasound (IVUS) would have provided
useful information, we were not able to perform it due to
the reimbursement issues. Magnetic resonance imaging
with gadolinium could not have been performed due to
unavailability of the method in our hospital as well as the
contraindication of adenosine administration due to the
patient’s history of asthma. In addition, another option
could explain this sequence of events—prolonged coronary
artery spasm which was repeated during the ﬁrst two coro-
nary angiographies. There are several facts pointing to the
unlikelihood of spasm: presence of occlusion on two con-
secutive angiographies with 5-day diﬀerence while the
patient was on full anti-ischemic therapy including nitrates
and presence of collaterals to RCA supplying territory, no
evidence of dynamic component of stenosis in angiograms
during two diﬀerent angiographies, as well as no evidence
of spasm tendency on the third angiography. However, ace-
tylcholine or ergonovine test during the last angiography,
when RCA was found patent, which could have revealed
the possibility of coronary artery spasm, was unfortunately
not done [10, 11]. Lamm et al. [6] suggested that CTO is
not a deﬁnitive state and collateral formation is just a bypass
to the natural occlusion resolution. Perhaps it happens more
often than we know because CTO patients are often treated
with medications and usually no control angiographies are
performed routinely. We hope that our data will help other
authors to understand better the patho(physio)logy of the
described unusual ﬁnding and encourage new basic studies
in this area.
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